Exelixis Inc. (EXEL)
NASDAQ: EXEL
· Real-Time Price · USD
36.93
0.76 (2.10%)
At close: May 12, 2025, 3:59 PM
37.50
1.54%
After-hours: May 12, 2025, 07:58 PM EDT
Exelixis Revenue Breakdown
| Period Ending | Jan 3, 2025 | Dec 29, 2023 | Dec 30, 2022 | Dec 31, 2021 | Jan 1, 2021 | Jan 3, 2020 | Dec 28, 2018 |
|---|---|---|---|---|---|---|---|
| Collaboration Revenue | 359.31M | 201.33M | 209.82M | 357.71M | 245.99M | 207.82M | 192.19M |
| Collaboration Revenue Growth | +78.47% | -4.05% | -41.34% | +45.42% | +18.36% | +8.14% | n/a |
| License Revenue | 349.24M | 178.63M | 162.06M | 1.08B | 167.29M | 759.95M | 619.28M |
| License Revenue Growth | +95.51% | +10.23% | -84.96% | +543.93% | -77.99% | +22.72% | n/a |
| Product Revenue | 1.81B | 1.63B | 1.4B | 1.45B | 741.55M | 957.62M | 738.53M |
| Product Revenue Growth | +11.08% | +16.25% | -3.56% | +95.93% | -22.56% | +29.67% | n/a |
| Product, Gross Revenue | 2.52B | 2.27B | 1.95B | -375.66M | 962.59M | -197.67M | n/a |
| Product, Gross Revenue Growth | +10.81% | +16.47% | -619.40% | -139.03% | -586.97% | n/a | n/a |
| Product, Sales Discounts And Allowances Revenue | -708.85M | -643.65M | -549.93M | n/a | -221.04M | n/a | n/a |
| Product, Sales Discounts And Allowances Revenue Growth | +10.13% | +17.04% | n/a | n/a | n/a | n/a | n/a |
| Service Revenue | 10.06M | 22.69M | 47.76M | n/a | 78.69M | n/a | n/a |
| Service Revenue Growth | -55.66% | -52.49% | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jan 3, 2025 | Sep 27, 2024 | Jun 28, 2024 | Mar 29, 2024 | Dec 29, 2023 | Sep 29, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 30, 2022 | Sep 30, 2022 | Jul 1, 2022 | Apr 1, 2022 | Dec 31, 2021 | Oct 1, 2021 | Jul 2, 2021 | Apr 2, 2021 | Jan 1, 2021 | Oct 2, 2020 | Jul 3, 2020 | Apr 3, 2020 | Jan 3, 2020 | Sep 27, 2019 | Jun 28, 2019 | Mar 29, 2019 | Dec 28, 2018 | Sep 28, 2018 | Jun 29, 2018 | Mar 30, 2018 | Dec 29, 2017 | Sep 29, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 30, 2016 | Sep 30, 2016 | Jul 1, 2016 | Apr 1, 2016 | Jan 1, 2016 | Oct 2, 2015 | Jul 3, 2015 | Apr 3, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 134.33M | 111.8M | 132.01M | 113.98M | 131.44M | 138.14M | 141.72M | 131.4M | 119.25M | 114.98M | 122.76M | 102.86M | 99.31M | 101.56M | 98.5M | 102.35M | 82.44M | 88.19M | 59.79M | 62.94M | 58.03M | 51.27M | 58.81M | 60.14M | 52.38M | 48.12M | 51.85M | 52.64M | 46.25M | 38.13M | 40.73M | 34.26M | 13M | 32.46M | 35.82M | 34.86M | 17.14M | 17.84M | 12.79M | 9.53M |
| Selling, General, and Administrative Revenue Growth | +20.15% | -15.31% | +15.82% | -13.28% | -4.85% | -2.53% | +7.86% | +10.19% | +3.71% | -6.33% | +19.34% | +3.58% | -2.21% | +3.11% | -3.77% | +24.15% | -6.52% | +47.49% | -5.00% | +8.47% | +13.19% | -12.84% | -2.20% | +14.82% | +8.85% | -7.20% | -1.50% | +13.83% | +21.29% | -6.38% | +18.88% | +163.50% | -59.95% | -9.38% | +2.77% | +103.33% | -3.92% | +39.51% | +34.18% | n/a |
| Research and Development Revenue | 249M | 222.57M | 211.15M | 227.69M | 244.67M | 332.58M | 232.57M | 234.25M | 336.82M | 198.84M | 199.48M | 156.67M | 222.27M | 163.37M | 148.79M | 159.29M | 154.28M | 176.76M | 114.93M | 101.88M | 94.45M | 97.3M | 81.93M | 63.29M | 57.27M | 44.74M | 42.49M | 37.76M | 32.2M | 28.54M | 28.21M | 23.21M | 23.8M | 20.26M | 22.98M | 28.93M | 23.47M | 26.09M | 24.51M | 22.28M |
| Research and Development Revenue Growth | +11.88% | +5.41% | -7.27% | -6.94% | -26.43% | +43.00% | -0.72% | -30.45% | +69.40% | -0.32% | +27.32% | -29.51% | +36.05% | +9.80% | -6.59% | +3.25% | -12.72% | +53.80% | +12.82% | +7.87% | -2.93% | +18.75% | +29.46% | +10.51% | +28.01% | +5.30% | +12.53% | +17.24% | +12.83% | +1.17% | +21.56% | -2.48% | +17.50% | -11.87% | -20.54% | +23.24% | -10.04% | +6.47% | +9.98% | n/a |